NCT02160665View on ClinicalTrials.gov

Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

866

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Plaque Psoriasis
Interventions
DRUG

Tazarotene Cream, 0.05%

Tazarotene Cream, 0.05% (G \& W Laboratories, Inc.)

DRUG

Vehicle

Vehicle of Test product (G \& W Laboratories, Inc.)

DRUG

Reference: Tazorac Cream, 0.05%

Reference: Tazorac (tazarotene) Cream, 0.05% (Allergan, Inc.)

Trial Locations (1)

60005

Altman Dermatology Associates, Arlington Heights

Sponsors
All Listed Sponsors
lead

G & W Laboratories Inc.

INDUSTRY

NCT02160665 - Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis | Biotech Hunter | Biotech Hunter